Skip to content

Predicting Stone Passage: Blood and Imaging Markers in Ureteric Stone Treatment

Role of hematological and radiological parameters in successful medical expulsion therapy for patients with ureteric calculus - An observational study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/11/097714
Enrollment
100
Registered
2025-11-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N201- Calculus of ureter

Interventions

Intervention1: Nil: Nil

Sponsors

SRM Medical College Hospital Research Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with a radiological diagnosis of a single ureteral stoneless than or equal to 10mm on non-contrast-enhanced computerized tomography (NCCT). Patients willing to receive medical expulsive therapy (tamsulosin 0.4 mg daily) and attend follow-up visits. Age more than 8 year

Exclusion criteria

Exclusion criteria: Multiple ureteral stones or concurrent renal stones. Solitary kidney. Associated chronic inflammatory conditions (e.g., autoimmune diseases). Positive urine culture or high fever on presentation. Renal impairment (serum creatinine significantly elevated). Patients lost to follow-up. Abnormal renal anatomy (such as ileal conduit/ horseshoe kidney)

Design outcomes

Primary

MeasureTime frame
To compare the other radiological factors (Eg. Stone size, location, hydronephrosis) between both the groups.Timepoint: 4 weeks

Secondary

MeasureTime frame
To compare the other radiological factors (Eg. Stone size, location, hydronephrosis) between both the groups.Timepoint: 4 weeks

Countries

India

Contacts

Public ContactBalaji Subramaniam

SRM Medical College Hospital Research Centre

hod.urolog.ktr@srmist.edu.in9841468834

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026